Luba Greenwood

Luba Greenwood has deep industry experience and expertise in mergers & acquisitions and strategic partnerships, ranging from billion-dollar deals to small strategic alliances. She advises large multinational corporations, start-ups, financial firms, and private equity and venture capital funds in biotechnology, pharma, technology, energy, finance, and defense industries, serving as a strategic advisor on deal structures, valuation, exit and global strategy, risk analysis and due diligence, negotiation strategy, and early stage and capital investments. Greenwood served as a Senior Mergers & Acquisitions counsel at Pfizer Inc., where she advised on risks in complex commercial transactions including mergers and acquisitions, asset purchases, joint ventures, divestitures, technology transfers, co-commercialization and co-development, collaboration, and in-licensing and our-licensing agreements and venture capital investments, working with cross-functional teams in business development, tax, antitrust, litigation, finance, R&D, and commercial. Prior to Pfizer, Greenwood practiced law at Wilmer Cutler Pickering Hale and Dorr in the Litigation and Securities Departments where she represented clients in securities, intellectual property, regulatory, and litigation matters.Luba Greenwood advises a number of early-stage technology companies, leading business development and strategy for a biotechnology company and serving as head of corporate development at a private merchant bank.Luba is an adjunct professor at Boston University School of Management where she teaches Business Law, and Boston University Law School where she teaches a course on the Life Sciences. She also lectures at Bentley University. She is a frequent speaker on topics relating to innovation, healthcare, biotechnology, intellectual property, and legal and regulatory risks.Luba serves on the board of the Longwood Symphony Orchestra, is a Co-chair of MassBio•s Entrepreneur•s University, mentor for the MIT 100K Entrepreneurship Competition, a judge for MassChallenge and the Young Entrepreneurs Initiative, and on a Steering Committee of the Boston Bar Association.In 2014, Luba she received the Science Club for Girls Catalyst Award for her commitment to fostering women talent and advocating for women in science and technology.

Luba Greenwood is the Chair Of The Board Of Directors at Kojin Therapeutics, based in United States, North America. With a background in Biotechnology, Luba Greenwood has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.